Cargando…

Exploration of beta-arrestin isoform signaling pathways in delta opioid receptor agonist-induced convulsions

The δ-opioid receptor (δOR) has been considered as a therapeutic target in multiple neurological and neuropsychiatric disorders particularly as δOR agonists are deemed safer alternatives relative to the more abuse-liable µ-opioid receptor drugs. Clinical development of δOR agonists, however, has bee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Blaine, Arryn T., Miao, Yiming, Yuan, Jinling, Palant, Sophia, Liu, Rebecca J., Zhang, Zhong-Yin, van Rijn, Richard. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428791/ https://www.ncbi.nlm.nih.gov/pubmed/36059958 http://dx.doi.org/10.3389/fphar.2022.914651

Ejemplares similares

ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment
por: French, Alexander R., et al.
Publicado: (2023)

Evaluation of Kratom Opioid Derivatives as Potential Treatment Option for Alcohol Use Disorder
por: Gutridge, Anna M., et al.
Publicado: (2021)

Treatment With the Delta Opioid Agonist UFP-512 Alleviates Chronic Inflammatory and Neuropathic Pain: Mechanisms Implicated
por: Polo, Sara, et al.
Publicado: (2019)

The Meta-Position of Phe(4) in Leu-Enkephalin Regulates Potency, Selectivity, Functional Activity, and Signaling Bias at the Delta and Mu Opioid Receptors
por: Cassell, Robert J., et al.
Publicado: (2019)

Cannabinoid CB1 and CB2 Receptor-Mediated Arrestin Translocation: Species, Subtype, and Agonist-Dependence
por: Ibsen, Mikkel Søes, et al.
Publicado: (2019)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist
por: Kevin, Richard C., et al.
Publicado: (2019)

Development of a novel cell-based, In-Cell Western/ERK assay system for the high-throughput screening of agonists acting on the delta-opioid receptor
por: Asghar, Junaid, et al.
Publicado: (2022)

Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist
por: Doi, Seira, et al.
Publicado: (2016)

In vitro and in vivo Pharmacological Activities of 14-O-Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
por: Lattanzi, Roberta, et al.
Publicado: (2018)

Comparative analyses of downstream signal transduction targets modulated after activation of the AT(1) receptor by two β-arrestin-biased agonists
por: Santos, Geisa A., et al.
Publicado: (2015)

Therapeutic Potential of Targeting ß-Arrestin
por: Bond, Richard A., et al.
Publicado: (2019)

Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose
por: Sharifi, Farrokh, et al.
Publicado: (2021)

Nitro-benzylideneoxymorphone, a bifunctional mu and delta opioid receptor ligand with high mu opioid receptor efficacy
por: Olson, Keith M., et al.
Publicado: (2023)

GPCR Signaling Regulation: The Role of GRKs and Arrestins
por: Gurevich, Vsevolod V., et al.
Publicado: (2019)

μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges
por: Salinsky, Leah M., et al.
Publicado: (2023)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Forebrain delta opioid receptors regulate the response of delta agonist in models of migraine and opioid-induced hyperalgesia
por: Dripps, Isaac J., et al.
Publicado: (2020)

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities
por: Meqbil, Yazan J., et al.
Publicado: (2021)

GRKs and β-Arrestins: “Gatekeepers” of Mitochondrial Function in the Failing Heart
por: Sorriento, Daniela, et al.
Publicado: (2019)

Desmetramadol Is Identified as a G-Protein Biased µ Opioid Receptor Agonist
por: Zebala, John A., et al.
Publicado: (2020)

Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers
por: Khani, Samira, et al.
Publicado: (2023)

Dezocine is a Biased Ligand without Significant Beta-Arrestin Activation of the mu Opioid Receptor
por: Grothusen, John, et al.
Publicado: (2022)

Nicotine Elicits Convulsive Seizures by Activating Amygdalar Neurons
por: Iha, Higor A., et al.
Publicado: (2017)

Quantitative proteomic analysis reveals the effects of mu opioid agonists on HT22 cells
por: Zhang, Xutong, et al.
Publicado: (2023)

Cytoplasmic Beta and Gamma Actin Isoforms Reorganization and Regulation in Tumor Cells in Culture and Tissue
por: Dugina, V. B., et al.
Publicado: (2022)

Triphenylmethane Dye Activation of Beta-Arrestin
por: Barak, Larry S., et al.
Publicado: (2013)

Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy
por: Lohman, Rink-Jan, et al.
Publicado: (2023)

New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis
por: Bagnato, Anna, et al.
Publicado: (2019)

The Effect of Cell Surface Expression and Linker Sequence on the Recruitment of Arrestin to the GIP Receptor
por: Al-Sabah, Suleiman, et al.
Publicado: (2020)

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors
por: Meqbil, Yazan J., et al.
Publicado: (2022)

In Vivo Delta Opioid Receptor Internalization Controls Behavioral Effects of Agonists
por: Pradhan, Amynah A. A., et al.
Publicado: (2009)

Effects of delta-opioid receptor agonist pretreatment on the cardiotoxicity of bupivacaine in rats
por: Wang, Chenran, et al.
Publicado: (2022)

Sex Differences in Kappa Opioid Receptor Agonist Mediated Attenuation of Chemotherapy-Induced Neuropathic Pain in Mice
por: Paton, Kelly F., et al.
Publicado: (2022)

Subacute toxicity evaluations of LPM3480392 in rats, a full µ-opioid receptor biased agonist
por: Ye, Liang, et al.
Publicado: (2023)

A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
por: Mores, Kendall L., et al.
Publicado: (2019)

Agonist-Promoted Phosphorylation and Internalization of the Kappa Opioid Receptor in Mouse Brains: Lack of Connection With Conditioned Place Aversion
por: Chen, Chongguang, et al.
Publicado: (2022)

Beta-Arrestins and Receptor Signaling in the Vascular Endothelium
por: Lee, Claudia, et al.
Publicado: (2020)

β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Pathway in Alcoholic Liver Disease
por: Sun, Ying-Yin, et al.
Publicado: (2018)

Delta Opioid Receptor Agonists Ameliorate Colonic Inflammation by Modulating Immune Responses
por: Nagata, Kazuki, et al.
Publicado: (2021)

Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons – Effects of Nerve Injury
por: Stötzner, Philip, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_o1fhe3l7jcf9lm0fa0nfdsjk2p